These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7688411)

  • 41. Real-time RT-PCR analysis of two epitope regions encoded by the VP2 gene of infectious bursal disease viruses.
    Mickael CS; Jackwood DJ
    J Virol Methods; 2005 Sep; 128(1-2):37-46. PubMed ID: 16023522
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infectious bursal disease subviral particles displaying the foot-and-mouth disease virus major antigenic site.
    Rémond M; Da Costa B; Riffault S; Parida S; Breard E; Lebreton F; Zientara S; Delmas B
    Vaccine; 2009 Jan; 27(1):93-8. PubMed ID: 18983883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in VP2 gene during the attenuation of very virulent infectious bursal disease virus strain Gx isolated in China.
    Wang XM; Zeng XW; Gao HL; Fu CY; Wei P
    Avian Dis; 2004; 48(1):77-83. PubMed ID: 15077800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic and antigenic characterization of infectious bursal disease viruses isolated in Italy during the period 2002-2005.
    Martin AM; Fallacara F; Barbieri I; Tosi G; Rivallan G; Eterradossi N; Ceruti R; Cordioli P
    Avian Dis; 2007 Dec; 51(4):863-72. PubMed ID: 18251395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two dominant neutralizing antigenic determinants of canine parvovirus are found on the threefold spike of the virus capsid.
    Strassheim ML; Gruenberg A; Veijalainen P; Sgro JY; Parrish CR
    Virology; 1994 Jan; 198(1):175-84. PubMed ID: 8259653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antigenic and immunogenic properties of baculovirus-expressed infectious bursal disease viral proteins.
    Dybing JK; Jackwood DJ
    Avian Dis; 1998; 42(1):80-91. PubMed ID: 9533084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mapping the neutralizing epitopes on the glycoprotein of infectious haematopoietic necrosis virus, a fish rhabdovirus.
    Huang C; Chien MS; Landolt M; Batts W; Winton J
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():3033-40. PubMed ID: 9000094
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virus-neutralizing and passively protective monoclonal antibodies to infectious bursal disease virus of chickens.
    Fahey KJ; McWaters P; Brown MA; Erny K; Murphy VJ; Hewish DR
    Avian Dis; 1991; 35(2):365-73. PubMed ID: 1713030
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sequence comparisons of the variable VP2 region of eight infectious bursal disease virus isolates.
    Dormitorio TV; Giambrone JJ; Duck LW
    Avian Dis; 1997; 41(1):36-44. PubMed ID: 9087318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insect cell-derived VP2 of infectious bursal disease virus confers protection against the disease in chickens.
    Pitcovski J; Di-Castro D; Shaaltiel Y; Azriel A; Gutter B; Yarkoni E; Michael A; Krispel S; Levi BZ
    Avian Dis; 1996; 40(4):753-61. PubMed ID: 8980802
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nucleotide sequence analysis of genome segment A of infectious bursal disease virus.
    Kibenge FS; Jackwood DJ; Mercado CC
    J Gen Virol; 1990 Mar; 71 ( Pt 3)():569-77. PubMed ID: 2155995
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epitope mapping studies with neutralizing and non-neutralizing monoclonal antibodies to the G1 and G2 envelope glycoproteins of Hantaan virus.
    Wang M; Pennock DG; Spik KW; Schmaljohn CS
    Virology; 1993 Dec; 197(2):757-66. PubMed ID: 7504368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Production and characterization of murine IgA monoclonal antibodies to the surface antigens of rhesus rotavirus.
    Giammarioli AM; Mackow ER; Fiore L; Greenberg HB; Ruggeri FM
    Virology; 1996 Nov; 225(1):97-110. PubMed ID: 8918537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neutralizing antibodies to human rhinovirus produced in laboratory animals and humans that recognize a linear sequence from VP2.
    Hastings GZ; Speller SA; Francis MJ
    J Gen Virol; 1990 Dec; 71 ( Pt 12)():3055-9. PubMed ID: 1703215
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antigenic and sequence heterogeneity of infectious bursal disease virus strains isolated in Australia.
    Sapats SI; Ignjatovic J
    Arch Virol; 2000; 145(4):773-85. PubMed ID: 10893155
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular basis for linkage of a continuous and discontinuous neutralization epitope on the structural polypeptide VP2 of poliovirus type 1.
    Wiegers KJ; Wetz K; Dernick R
    J Virol; 1990 Mar; 64(3):1283-9. PubMed ID: 1689392
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular basis of antigenic variation in infectious bursal disease virus.
    Vakharia VN; He J; Ahamed B; Snyder DB
    Virus Res; 1994 Feb; 31(2):265-73. PubMed ID: 8178574
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of residues in VP2 that contribute to poliovirus neutralization antigenic site 3B.
    Reynolds C; Page G; Zhou H; Chow M
    Virology; 1991 Sep; 184(1):391-6. PubMed ID: 1714663
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recombinant infectious bursal disease virus carrying hepatitis C virus epitopes.
    Upadhyay C; Ammayappan A; Patel D; Kovesdi I; Vakharia VN
    J Virol; 2011 Feb; 85(3):1408-14. PubMed ID: 21106739
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glycosylation, an important modifier of rotavirus antigenicity.
    Caust J; Dyall-Smith ML; Lazdins I; Holmes IH
    Arch Virol; 1987; 96(3-4):123-34. PubMed ID: 2444193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.